Oasis Diagnostics Corporation

Oasis Diagnostics Corporation, founded in 2002 and based in Vancouver, Washington, specializes in the development of non-invasive oral fluid and saliva collection tools and diagnostic technologies. The company designs proprietary products, including saliva collection kits for DNA, RNA, and protein analysis, as well as rapid point-of-care testing platforms like VerOFy and reading modules such as LIAM. Beyond its diagnostic portfolio, Oasis provides custom product development services, guiding other biotech and diagnostic firms through design, prototyping, tooling, and manufacturing to bring specialized specimen collection tools to market.

These technologies are engineered to bridge the gap between research and clinical environments, enabling more effective screening and early disease detection by utilizing non-invasive samples. By facilitating the integration of precision diagnostics into diverse settings, such as dental care through recent strategic partnerships, the company aims to enhance healthcare quality and systemic disease management. With a portfolio of international patents, Oasis serves a global customer base, providing innovative, patient-friendly alternatives to traditional, invasive diagnostic sampling methods.